Role of skeletal muscle mitochondrial density on exercise-stimulated lipid oxidation

Obesity

Volumn 20, Issue 7, 2012, Pages 1387-1393

  Galgani, Jose E ^a   Johannsen, Neil M ^b   Bajpeyi, Sudip ^b   Costford, Sheila R ^c   Zhang, Zhengyu ^b   Gupta, Alok K ^b   Ravussin, Eric ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; CITRATE SYNTHASE; GLUCOSE; INSULIN; LACTIC ACID; PALMITIC ACID;

ADULT; AEROBIC CAPACITY; ARTICLE; BLOOD SAMPLING; CATECHOLAMINE BLOOD LEVEL; CELL DENSITY; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; EX VIVO STUDY; EXERCISE; EXERCISE INTENSITY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INSULIN BLOOD LEVEL; LACTATE BLOOD LEVEL; LIPID DIET; LIPID OXIDATION; LUNG GAS EXCHANGE; MALE; MAXIMUM AEROBIC CAPACITY; MUSCLE BIOPSY; MUSCLE MITOCHONDRION; NORMAL HUMAN; RESPIRATORY QUOTIENT; SKELETAL MUSCLE; VASTUS LATERALIS MUSCLE;

ADOLESCENT; ADULT; BODY MASS INDEX; CERAMIDES; CITRATE (SI)-SYNTHASE; CROSS-SECTIONAL STUDIES; DIET, HIGH-FAT; EXERCISE; FASTING; FATTY ACIDS; HUMANS; INSULIN RESISTANCE; LIPIDS; MALE; MUSCLE, SKELETAL; OXIDATION-REDUCTION; RETROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 84862853455     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.166     Document Type: Article

References (42)

1. Moro C, Galgani JE, Luu L et al. Influence of gender, obesity, and muscle lipase activity on intramyocellular lipids in sedentary individuals. J Clin Endocrinol Metab 2009;94:3440-3447.
2. Holland WL, Brozinick JT, Wang LP et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 2007;5:167-179.
3. Yu C, Chen Y, Cline GW et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002;277:50230-50236.
4. Patti ME, Corvera S. The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr Rev 2010;31:364-395.
5. Koves TR, Ussher JR, Noland RC et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 2008;7:45-56.
6. Sparks LM, Xie H, Koza RA et al. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 2005;54:1926-1933.
7. Turner N, Heilbronn LK. Is mitochondrial dysfunction a cause of insulin resistance? Trends Endocrinol Metab 2008;19:324-330.
8. Kelley DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 2000;49:677-683.
9. Holloszy JO. Skeletal muscle "mitochondrial deficiency" does not mediate insulin resistance. Am J Clin Nutr 2009;89:463S-466S.
10. Galgani JE, Heilbronn LK, Azuma K et al.; Look AHEAD Adipose Research Group. Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate. Diabetes 2008;57:841-845.
11. Han DH, Nolte LA, Ju JS et al. UCP-mediated energy depletion in skeletal muscle increases glucose transport despite lipid accumulation and mitochondrial dysfunction. Am J Physiol Endocrinol Metab 2004;286: E347-E353.
12. Handschin C, Choi CS, Chin S et al. Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal musclepancreatic beta cell crosstalk. J Clin Invest 2007;117:3463-3474.
13. Wredenberg A, Freyer C, Sandström ME et al. Respiratory chain dysfunction in skeletal muscle does not cause insulin resistance. Biochem Biophys Res Commun 2006;350:202-207.
14. Rabøl R, Boushel R, Dela F. Mitochondrial oxidative function and type 2 diabetes. Appl Physiol Nutr Metab 2006;31:675-683.
15. Blaak EE, van Aggel-Leijssen DP, Wagenmakers AJ, Saris WH, van Baak MA. Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes 2000;49:2102-2107.
16. Braun B, Sharoff C, Chipkin SR, Beaudoin F. Effects of insulin resistance on substrate utilization during exercise in overweight women. J Appl Physiol 2004;97:991-997.
17. Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ, Saris WH. Plasma free Fatty Acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes 2001;50:2548-2554.
18. Redman LM, Heilbronn LK, Martin CK et al.; Pennington CALERIE Team. Metabolic and behavioral compensations in response to caloric restriction: implications for the maintenance of weight loss. PLoS ONE 2009;4:e4377.
19. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 1970;2:92-98.
20. Galgani JE, Ryan DH, Ravussin E. Effect of capsinoids on energy metabolism in human subjects. Br J Nutr 2010;103:38-42.
21. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 1983;55:628-634.
22. Ukropcova B, Sereda O, de Jonge L et al. Family history of diabetes links impaired substrate switching and reduced mitochondrial content in skeletal muscle. Diabetes 2007;56:720-727.
23. Costford SR, Bajpeyi S, Pasarica M et al. Skeletal muscle NAMPT is induced by exercise in humans. Am J Physiol Endocrinol Metab 2010;298: E117-E126.
24. Kim JY, Hickner RC, Cortright RL, Dohm GL, Houmard JA. Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 2000;279:E1039-E1044.
25. Bajpeyi S, Tanner CJ, Slentz CA et al. Effect of exercise intensity and volume on persistence of insulin sensitivity during training cessation. J Appl Physiol 2009;106:1079-1085.
26. Holloszy JO, Oscai LB, Don IJ, Molé PA. Mitochondrial citric acid cycle and related enzymes: adaptive response to exercise. Biochem Biophys Res Commun 1970;40:1368-1373.
27. Simoneau JA, Colberg SR, Thaete FL, Kelley DE. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB J 1995;9:273-278.
28. Kelley DE, Goodpaster B, Wing RR, Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 1999;277:E1130-E1141.
29. Kelley DE, Simoneau JA. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 1994;94:2349-2356.
30. Parikh H, Nilsson E, Ling C et al. Molecular correlates for maximal oxygen uptake and type 1 fibers. Am J Physiol Endocrinol Metab 2008;294: E1152-E1159.
31. Morino K, Petersen KF, Dufour S et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest 2005;115:3587-3593.
32. Lattuada G, Costantino F, Caumo A et al. Reduced whole-body lipid oxidation is associated with insulin resistance, but not with intramyocellular lipid content in offspring of type 2 diabetic patients. Diabetologia 2005;48:741-747.
33. Goodpaster BH, Katsiaras A, Kelley DE. Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity. Diabetes 2003;52:2191-2197.
34. Zurlo F, Larson K, Bogardus C, Ravussin E. Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest 1990;86:1423-1427.
35. Hwang H, Bowen BP, Lefort N et al. Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes. Diabetes 2010;59:33-42.
36. Mogensen M, Sahlin K, Fernström M et al. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 2007;56:1592-1599.
37. Phielix E, Schrauwen-Hinderling VB, Mensink M et al. Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients. Diabetes 2008;57:2943-2949.
38. Ritov VB, Menshikova EV, Azuma K et al. Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity. Am J Physiol Endocrinol Metab 2010;298:E49-E58.
39. Schrauwen-Hinderling VB, Kooi ME, Hesselink MK et al. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 2007;50:113-120.
40. Galgani JE, Moro C, Ravussin E. Metabolic flexibility and insulin resistance. Am J Physiol Endocrinol Metab 2008;295:E1009-E1017.
41. Rolfe DF, Brown GC. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev 1997;77:731-758.
42. Rimbert V, Vidal H, Duché P et al. Rapid down-regulation of mitochondrial fat metabolism in human muscle after training cessation is dissociated from changes in insulin sensitivity. FEBS Lett 2009;583:2927-2933.